Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Dawson James started coverage on shares of Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and […]

Related Keywords

Dawson James ,Zembrace Symtouch ,Tonix Pharmaceuticals ,Exchange Commission ,Nasdaq ,Hedge Funds Weigh In On Tonix Pharmaceuticals ,Sabby Management ,Tonix Pharmaceuticals Stock ,News Ratings For Tonix Pharmaceuticals Daily ,Tonix Pharmaceuticals Holding Corp ,Free Report ,Get Free Report ,Tonix Pharmaceuticals Holding ,Pharmaceuticals Holding Corp ,Tonix Pharmaceuticals Daily ,Nasdaq Tnxp ,Tnxp ,Medical ,Initiated Coverage ,Stocknews Com ,